Association of IGHM polymorphisms with susceptibility to type 1 diabetes

Immunol Res. 2022 Jun;70(3):325-330. doi: 10.1007/s12026-021-09252-x. Epub 2022 Jan 20.

Abstract

Differentiation of B lymphocytes is accompanied by a regulated switch in the expression pattern and stability of surface and secretory immunoglobulins (Igs). Several lines of evidence show that autoimmune responses evolving in much autoimmune pathologies were associated with a high level of humoral Ig, but their pathogenic role remains elusive. The aim of this study was to test the hypothesis that variants at the immunoglobulin heavy-chain IGH locus are genetic determinants to T1D susceptibility. Here, we tested the genetic association of the variants of the immunoglobulin heavy-chain IGH locus as a genetic determinant to T1D susceptibility. A total of 255 subjects from 59 Tunisian families were genotyped for 15 SNPs mapping in 4 regions in IGH locus. We found that rs1950942, rs2180790, rs1808152, and rs1956596 of IGHM and rs2516751 variant located in the IGHA1/IGHG2 region were significantly associated with a risk for T1D p = 7E-3; p = 0.03; p = 0.02; p = 0.043; and p = 3.65E-5, respectively. The TATGG haplotype derived from LD across three SNPs from IGHM gene and two SNPs from IGHD gene was significantly over-transmitted from parents to affect offspring. Our results suggest that genetic variants at the IGH locus are associated with T1D susceptibility. These variations may predispose to IgG AutoAbs production against pancreatic antigens and AutoAbs multi-reactivity, leading to T1D development.

Keywords: Autoantibodies; IgH locus; IgM; Polymorphism; Type 1 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus, Type 1* / genetics
  • Genetic Predisposition to Disease
  • Genotype
  • Haplotypes
  • Humans
  • Immunoglobulin mu-Chains* / genetics
  • Immunoglobulins / genetics
  • Polymorphism, Single Nucleotide

Substances

  • IGHM protein, human
  • Immunoglobulin mu-Chains
  • Immunoglobulins